{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:27:09Z","timestamp":1788798429791,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T00:00:00Z","timestamp":1349654400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-459","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T10:14:41Z","timestamp":1349691281000},"source":"Crossref","is-referenced-by-count":27,"title":["Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Wolfgang","family":"Otto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"Rubenwolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Martin","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"R\u00f6\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Hofst\u00e4dter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf F","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Denzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,8]]},"reference":[{"key":"3443_CR1","doi-asserted-by":"crossref","first-page":"17497","DOI":"10.1016\/S0021-9258(18)45408-7","volume":"262","author":"P Agre","year":"1987","unstructured":"Agre P, Saboori AM, Asimos A, Smith BL: Purification and partial characterization of the Mr 30,000 integral membrane protein as- sociated with the erythrocyte Rh(D) antigen. J Biol Chem. 1987, 262: 17497-17503.","journal-title":"J Biol Chem"},{"issue":"5055","key":"3443_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.256.5055.385","volume":"256","author":"GM Preston","year":"1992","unstructured":"Preston GM, Carroll TP, Guggino WB, Agre P: Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science. 1992, 256 (5055): 385-387. 10.1126\/science.256.5055.385.","journal-title":"Science"},{"issue":"2","key":"3443_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1083\/jcb.120.2.371","volume":"120","author":"S Nielsen","year":"1993","unstructured":"Nielsen S, Smith BL, Christensen EI, Knepper MA, Agre P: CHIP28 water channels are localized in constitutively water-permeable segments of the nephron. J Cell Biol. 1993, 120 (2): 371-383. 10.1083\/jcb.120.2.371.","journal-title":"J Cell Biol"},{"issue":"3 Pt 2","key":"3443_CR4","first-page":"F461","volume":"265","author":"P Agre","year":"1993","unstructured":"Agre P, Sasaki S, Chrispeels MJ: Aquaporins: a family of water channel proteins. Am J Physiol. 1993, 265 (3 Pt 2): F461-","journal-title":"Am J Physiol"},{"issue":"5","key":"3443_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00041552-199309000-00003","volume":"2","author":"HW Harris Jr","year":"1993","unstructured":"Harris HW, Zeidel ML: Water channels. Curr Opin Nephrol Hypertens. 1993, 2 (5): 699-707. 10.1097\/00041552-199309000-00003.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3443_CR6","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1002\/pmic.200600212","volume":"6","author":"F Magni","year":"2006","unstructured":"Magni F, Sarto C, Ticozzi D, et al: Proteomic knowledge of human aquaporins. Proteomics. 2006, 6: 5637-5649. 10.1002\/pmic.200600212.","journal-title":"Proteomics"},{"key":"3443_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0014-5793(03)01083-4","volume":"555","author":"P Agre","year":"2003","unstructured":"Agre P, Kozono D: Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett. 2003, 555: 72-78. 10.1016\/S0014-5793(03)01083-4.","journal-title":"FEBS Lett"},{"key":"3443_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1517\/14728222.10.6.889","volume":"10","author":"K Jeyaseelan","year":"2006","unstructured":"Jeyaseelan K, Sepramaniam S, Armugam A, Wintour EM: Aquaporins: a promising target for drug development. Expert Opin Ther Targets. 2006, 10: 889-909. 10.1517\/14728222.10.6.889.","journal-title":"Expert Opin Ther Targets"},{"key":"3443_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nature03460","volume":"434","author":"S Saadoun","year":"2005","unstructured":"Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS: Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature. 2005, 434: 786-792. 10.1038\/nature03460.","journal-title":"Nature"},{"issue":"12","key":"3443_CR10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.4161\/cbt.9.12.11705","volume":"9","author":"Y Huang","year":"2010","unstructured":"Huang Y, Zhu Z, Sun M, Wang J, Guo R, Shen L, Wu W: Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther. 2010, 9 (12): 1000-1007. 10.4161\/cbt.9.12.11705.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"3443_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.eururo.2008.08.013","volume":"56","author":"PC Rubenwolf","year":"2009","unstructured":"Rubenwolf PC, Georgopoulos NT, Clements LA, Feather S, Holland P, Thomas DF, Southgate J: Expression and localisation of aquaporin water channels in human urothelium in situ and in vitro. Eur Urol. 2009, 56 (6): 1013-1023. 10.1016\/j.eururo.2008.08.013.","journal-title":"Eur Urol"},{"issue":"6","key":"3443_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.eururo.2008.08.014","volume":"56","author":"D Dhawan","year":"2009","unstructured":"Dhawan D: Editorial comment on: Expression and localization of aquaporin water channels in human urothelium in situ and in vitro. Eur Urol. 2009, 56 (6): 1023-1024. 10.1016\/j.eururo.2008.08.014.","journal-title":"Eur Urol"},{"issue":"3","key":"3443_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.eururo.2011.12.023","volume":"61","author":"PC Rubenwolf","year":"2012","unstructured":"Rubenwolf PC, Denzinger S, Otto W: Aquaporin 3 protein expression in transitional cell carcinoma: a potential marker with regard to tumour progression and prognosis?. Eur Urol. 2012, 61 (3): 627-628. 10.1016\/j.eururo.2011.12.023.","journal-title":"Eur Urol"},{"issue":"1","key":"3443_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","volume":"169","author":"O Shahin","year":"2003","unstructured":"Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE: A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol. 2003, 169 (1): 96-100. 10.1016\/S0022-5347(05)64044-X. discussion 100","journal-title":"J Urol"},{"key":"3443_CR15","volume-title":"TNM Klassifikation maligner Tumoren, UICC","author":"CH Wittekind","year":"2010","unstructured":"Wittekind CH, Meyer HJ, Bootz F: TNM Klassifikation maligner Tumoren, UICC. 2010, Heidelberg: Springer, 7","edition":"7"},{"issue":"3","key":"3443_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1464-410X.2010.09515.x","volume":"107","author":"W Otto","year":"2011","unstructured":"Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofst\u00e4dter F, Hartmann A, Bertz S: The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int. 2011, 107 (3): 404-408. 10.1111\/j.1464-410X.2010.09515.x.","journal-title":"BJU Int"},{"issue":"5","key":"3443_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.eururo.2009.03.052","volume":"57","author":"M May","year":"2010","unstructured":"May M, Brookman-Amissah S, Roigas J, Hartmann A, St\u00f6rkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Gunia S: Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol. 2010, 57 (5): 850-858. 10.1016\/j.eururo.2009.03.052.","journal-title":"Eur Urol"},{"key":"3443_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","volume":"54","author":"R Hurle","year":"1999","unstructured":"Hurle R, Losa A, Manzetti A, Lembo A: Intravesical bacillus Calmette-Guerin in stage T1, grade 3 bladder cancer therapy: a 7-year follow-up. Urology. 1999, 54: 258-263. 10.1016\/S0090-4295(99)00116-8.","journal-title":"Urology"},{"key":"3443_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000019664","volume":"34","author":"T Lebret","year":"1998","unstructured":"Lebret T, Gaudez F, Herve JM, Barre P, Lugagne PM, Botto H: Low-dose BCG instillations in the treatment of Stage T1 Grade 3 bladder tumours: recurrence, progression and success. Eur Urol. 1998, 34: 67-72. 10.1159\/000019664.","journal-title":"Eur Urol"},{"key":"3443_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","volume":"48","author":"A Orsola","year":"2005","unstructured":"Orsola A, Trias I, Ravent\u00f3s CX, Espanol I, Cecchini L, B\u00facar S, Salinas D, Orsola I: Initial High-Grade T1 Urothelial Cell Carcinoma: Feasibility and Prognostic Significance of Lamina Propria Invasion Microstaging (T1a\/b\/c) in BCG-Treated and BCG-Non-Treated Patients. Eur Urol. 2005, 48: 231-238. 10.1016\/j.eururo.2005.04.013.","journal-title":"Eur Urol"},{"issue":"4","key":"3443_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/00365590902854354","volume":"43","author":"S Denzinger","year":"2009","unstructured":"Denzinger S, Burger M, Fritsche HM, Bertz S, Hofst\u00e4dter F, Wieland WF, Hartmann A, Otto W: Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder. Scand J Urol Nephrol. 2009, 43 (4): 282-287. 10.1080\/00365590902854354.","journal-title":"Scand J Urol Nephrol"},{"key":"3443_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S0022-5347(05)67523-4","volume":"163","author":"M Brake","year":"2000","unstructured":"Brake M, Loertzer H, Horsch R, Keller H: Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol. 2000, 163: 1697-1705. 10.1016\/S0022-5347(05)67523-4.","journal-title":"J Urol"},{"key":"3443_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","volume":"59","author":"V Pansadoro","year":"2002","unstructured":"Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN: Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology. 2002, 59: 227-231. 10.1016\/S0090-4295(01)01603-X.","journal-title":"Urology"},{"issue":"4","key":"3443_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1365-2559.2011.03989.x","volume":"59","author":"S Bertz","year":"2011","unstructured":"Bertz S, Denzinger S, Otto W, Wieland WF, Stoehr R, Hofstaedter F, Hartmann A: Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series. Histopathology. 2011, 59 (4): 722-732. 10.1111\/j.1365-2559.2011.03989.x.","journal-title":"Histopathology"},{"issue":"2","key":"3443_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0210-4806(03)72891-5","volume":"27","author":"A Rodr\u00edguez Alonso","year":"2003","unstructured":"Rodr\u00edguez Alonso A, Pita Fern\u00e1ndez S, Gonz\u00e1lez-Carrer\u00f3 J, Nogueira March JL: [Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki67]. Actas Urol Esp. 2003, 27 (2): 132-141.","journal-title":"Actas Urol Esp"},{"issue":"3","key":"3443_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1309\/LTFU3UUMBY095HUM","volume":"122","author":"A Lopez-Beltran","year":"2004","unstructured":"Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R: Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol. 2004, 122 (3): 444-452. 10.1309\/LTFU3UUMBY095HUM.","journal-title":"Am J Clin Pathol"},{"key":"3443_CR27","volume-title":"Urol Oncol","author":"J Park","year":"2011","unstructured":"Park J, Song C, Shin E, Hong JH, Kim CS, Ahn H: Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?. Urol Oncol. 2011, Epub ahead of print"},{"issue":"6","key":"3443_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1349-7006.2011.01927.x","volume":"102","author":"M Kusayama","year":"2011","unstructured":"Kusayama M, Wada K, Nagata M, Ishimoto S, Takahashi H, Yoneda M, Nakajima A, Okura M, Kogo M, Kamisaki Y: Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci. 2011, 102 (6): 1128-11236. 10.1111\/j.1349-7006.2011.01927.x.","journal-title":"Cancer Sci"},{"key":"3443_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1756-9966-30-86","volume":"30","author":"H Xu","year":"2011","unstructured":"Xu H, Xu Y, Zhang W, Shen L, Yang L, Xu Z: Aquaporin-3 positively regulates matrix metalloproteinases via PI3K\/AKT signal pathway in human gastric carcinoma SGC7901 cells. J Exp Clin Cancer Res. 2011, 30: 86-10.1186\/1756-9966-30-86.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"3443_CR30","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/sj.bjc.6605093","volume":"100","author":"M Ismail","year":"2009","unstructured":"Ismail M, Bokaee S, Morgan R, Davies J, Harrington KJ, Pandha H: Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. Br J Cancer. 2009, 100 (12): 1889-1895. 10.1038\/sj.bjc.6605093.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-459\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T02:27:50Z","timestamp":1643509670000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3443"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-459","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,8]]},"article-number":"459"}}